BioStem Technologies, Inc.
BSEM · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $302 | $17 | $7 | $4 |
| % Growth | 1,708.9% | 142.7% | 58.4% | – |
| Cost of Goods Sold | $14 | $1 | $1 | $1 |
| Gross Profit | $288 | $15 | $6 | $3 |
| % Margin | 95.4% | 92.4% | 87.2% | 66% |
| R&D Expenses | $2 | $0 | $0 | $0 |
| G&A Expenses | $19 | $11 | $10 | $4 |
| SG&A Expenses | $255 | $23 | $10 | $4 |
| Sales & Mktg Exp. | $236 | $12 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $257 | $23 | $11 | $4 |
| Operating Income | $31 | -$8 | -$5 | -$2 |
| % Margin | 10.3% | -46.6% | -68.1% | -37% |
| Other Income/Exp. Net | -$1 | -$1 | -$3 | $0 |
| Pre-Tax Income | $31 | -$8 | -$7 | -$1 |
| Tax Expense | -$1 | $0 | $0 | $0 |
| Net Income | $32 | -$8 | -$7 | -$1 |
| % Margin | 10.6% | -50.8% | -102.9% | -33.3% |
| EPS | 1.95 | -0.62 | -0.62 | -0.12 |
| % Growth | 414.5% | 0% | -416.7% | – |
| EPS Diluted | 1.47 | -0.62 | -0.62 | -0.12 |
| Weighted Avg Shares Out | 16 | 14 | 11 | 12 |
| Weighted Avg Shares Out Dil | 22 | 14 | 11 | 12 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $0 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $31 | -$8 | -$7 | -$1 |
| % Margin | 10.4% | -45.3% | -94.8% | -13.9% |